{"id":28342,"date":"2020-07-16T19:45:50","date_gmt":"2020-07-17T01:45:50","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=28342"},"modified":"2020-07-16T19:47:03","modified_gmt":"2020-07-17T01:47:03","slug":"animal-health-news-notes-for-july-17-2020","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-july-17-2020\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 17 de julho de 2020"},"content":{"rendered":"<p>***********************************<br \/>\n<strong>Brakke Consulting&#8217;s <\/strong><br \/>\n<strong>Animal Health News &amp; Notes for July 17<\/strong><strong>, 2020<\/strong><br \/>\n<em>Copyright \u00a9 Brakke Consulting<br \/>\n<\/em><em>Editor: Lynn Fondon DVM MBA<br \/>\n<\/em>************************************<br \/>\nIN THE NEWS:<\/p>\n<p><u>Other News<br \/>\n<\/u>Antech Diagnostics<br \/>\nBayer<br \/>\nBiomin<br \/>\nElanco (Bayer)<br \/>\nElanco (Neogen)<br \/>\nDechra<br \/>\nGravity Payments<br \/>\nGrowSafe Systems<br \/>\nHoverHeat<br \/>\nInvetx<br \/>\nKemin Industries<br \/>\nLexaGene<br \/>\nNeogen (Elanco)<br \/>\nNeogen (Soleris)<br \/>\nPetIQ<br \/>\nTwist Bioscience<br \/>\nVet2Pet<br \/>\nVetCell Therapeutics<br \/>\nVytelle<br \/>\nWheatsheaf Group<br \/>\nZoetis<\/p>\n<p><strong>************************************<br \/>\nCOMPANY NEWS RELEASES<\/strong><\/p>\n<ul>\n<li><strong>Elanco Animal Health Incorporated<\/strong> announced that the company has received unanimous approval from the U.S. Federal Trade Commission (FTC) for its acquisition of <strong>Bayer Animal Health<\/strong>. The FTC\u2019s approval is conditional on the following proposed divestitures: Worldwide rights for Elanco\u2019s Osurnia, a treatment for otitis externa in dogs, being sold to <strong>Dechra Pharmaceuticals<\/strong> PLC; US rights for Elanco\u2019s Capstar, an oral tablet that kills fleas in dogs and cats, being sold to <strong>PetIQ<\/strong>, Inc.; US rights for Elanco\u2019s StandGuard, a pour-on treatment for horn fly and lice control in beef cattle, being sold to <strong>Neogen Corporation<\/strong>. The FTC decision represents the final antitrust clearance needed to complete the transaction, which continues on track for closing at the beginning of August. Elanco also received consent from Canada\u2019s Competition Bureau, pending the divestiture of Osurnia and Bayer\u2019s Profender, as well as Elanco&#8217;s commitment to forego acquiring the Canadian distribution rights to Bayer&#8217;s Tempo, Credo, QuickBayt and Annihilator Polyzone poultry insecticides. <em>(company press release, Newswire.ca)<\/em><\/li>\n<li>The USDA\u2019s Animal &amp; Plant Health Inspection Service (APHIS) is seeking public comment on a petition from <strong>Zoetis<\/strong> seeking approval to produce foot and mouth disease (FMD) vaccine consisting of a modified non-infectious and non-transmissible strain of the virus on the US mainland. The manufacturer asserts that because the FMD virus is no longer able to produce infection, it should not be considered a live virus of FMD and should be able to be produced on the US mainland. Public comments will be accepted through Sept. 14, 2020. To submit a comment,<a href=\"https:\/\/www.federalregister.gov\/d\/2020-15031\"> click here.<\/a> <em>(USDA, Feed Strategy)<\/em><\/li>\n<li><strong>Neogen Corporation<\/strong> announced that it plans to acquire the US (including territories) rights to <strong>Elanco<\/strong>\u2019s StandGuard Pour-on for horn fly and lice control in beef cattle, and related assets. Financial terms were not disclosed. <em>(company press release)<\/em><\/li>\n<li><strong>Antech Diagnostics<\/strong> announced the launch of the Canine CE-IBD assay, designed to determine whether a dog\u2019s chronic gastrointestinal symptoms correspond with Inflammatory Bowel Disease (IBD). The test relies on three novel serologic biomarkers to diagnose and manage IBD<em>. (IHS Markit Connect)<\/em><\/li>\n<li><strong>Neogen Corporation<\/strong> announced the launch of Soleris Next Generation (NG), an advanced test system that automatically detects microorganisms in a fraction of the time of traditional testing methods. <em>(company press release)<\/em><\/li>\n<li><strong>Kemin Industries <\/strong>announced that it has acquired a US patent application from the Kansas State University Research Foundation for a method to control African swine fever virus (ASFV) in feed and feed ingredients using its Sal CURB Liquid Antimicrobial pathogen control product. <em>(Feedstuffs)<\/em><\/li>\n<li><strong>VetCell Therapeutics<\/strong> announced it has received authorization from the FDA to start a country-wide investigational clinical trial, in collaboration with researchers from the UC Davis&#8217; Veterinary Institute for Regenerative Cures, of its DentaHeal cell therapy product for treatment for feline chronic gingivostomatitis (FCGS). DentaHeal is an allogenic, adipose-derived mesenchymal stem cell (MSC) therapy. <em>(IHS Markit Connect)<\/em><\/li>\n<li><strong>Vytelle <\/strong>and <strong>GrowSafe Systems<\/strong>, Ltd. announced the combining of their companies with the aim of accelerating genetic advances in bovine biotechnology. The companies will operate as a single precision livestock company under the Vytelle brand. With the combined capabilities of the new Vytelle, cattle producers will be able to convert individual animal performance data into genetic progress. Both companies are owned by UK-based <strong>Wheatsheaf Group<\/strong>. <em>(company press release)<\/em><\/li>\n<li><strong>Vet2Pet<\/strong> and<strong> Gravity Payments<\/strong> announced they have partnered to bring virtual payments to veterinary hospitals in the US. <em>(company press release)<\/em><\/li>\n<li>The inventor of the Hug-U-Vac surgical positioning system for human and veterinary patients has released another product: the <strong>HoverHeat<\/strong> warming device. HoverHeat supports normal body temperature when placed under a veterinary patient and connected to a warm air blower.<em> (Todays Veterinary Business)<\/em><\/li>\n<li><strong>Invetx<\/strong> announced that it has partnered with <strong>Twist Bioscience <\/strong>to engineer and optimize monoclonal antibodies as part of its novel discovery platform to create therapeutics for veterinary animals, joining existing collaborators AbCellera and Wuxi Biologics. <em>(company press release)<\/em><\/li>\n<li><strong>LexaGene<\/strong> announced it expects to launch its MiQLab, a fully-automated genetic analyzer, in September. The MiQLab is designed to deliver reference laboratory-quality data at the point of care. The technology can screen samples for up to 27 different targets simultaneously to detect pathogens and antimicrobial resistance factors, and can generate results in around one hour.<em> (IHS Markit Connect)<\/em><\/li>\n<li>EU <strong>Biomin<\/strong> announced it has secured European zootechnical authorization for the use of new capsule technology in its Digestarom DC Power feed additive for poultry. The capsule technology ensures plant-based active compounds in the feed additive are protected during feed processing and are released through the gastrointestinal tract slowly for maximum effectiveness.<em> (IHS Markit Connect)<\/em><\/li>\n<\/ul>\n<p>***********************************<br \/>\n<strong>ANIMAL HEALTH STOCK PRICE TRACKER<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-28343\" src=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg\" alt=\"\" width=\"541\" height=\"422\" srcset=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg 541w, https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17-480x374.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 541px, 100vw\" \/><br \/>\n***********************************<br \/>\n<strong>ANIMAL HEALTH NEWS<\/strong><\/p>\n<ul>\n<li>US &#8211; CWD The USDA&#8217;s Animal &amp; Plant Health Inspection Service (APHIS) announced that it is making available up to $3.5 million for state and tribal governments to carry out research and management activities to help combat chronic wasting disease (CWD) in farmed and wild deer and elk populations. Priority will be given to areas that have already detected CWD and implemented CWD monitoring and surveillance programs or that propose to create control programs. <em>(Feedstuffs)<\/em><\/li>\n<li>US &#8211; MUMS The FDA has released revised draft guidance to help researchers and animal drug sponsors navigate the pathway to approval for animal drugs intended for minor uses and minor species (MUMS). Draft Guidance for Industry #61, entitled \u201cSpecial Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species,\u201d will be available for comment for 120 days, starting July 15, 2020 through November 12, 2020. <a href=\"https:\/\/www.fda.gov\/animal-veterinary\/cvm-updates\/fda-issues-revised-draft-guidance-assist-sponsors-animal-drugs-minor-uses-and-minor-species?utm_campaign=7-14-2020-GFI61&amp;utm_medium=email&amp;utm_source=Eloqua\">Click here<\/a> for more information.<em> (FDA)<\/em><\/li>\n<li>US &#8211; FDA The FDA announced the availability of four draft guidance documents to help facilitate the development of New Animal Drug submissions. <a href=\"https:\/\/www.fda.gov\/animal-veterinary\/cvm-updates\/fda-issues-draft-guidances-help-facilitate-development-new-animal-drug-submissions?utm_campaign=7-14-2020-GFI265-268&amp;utm_medium=email&amp;utm_source=Eloqua\">Click here<\/a>\u00a0for more information. <em>(FDA)<\/em><\/li>\n<\/ul>\n<p>************************************<br \/>\n<strong>BRAKKE CONSULTING VIEWPOINT<\/strong><br \/>\nIn some respects, the underlying theme of this week\u2019s newsletter is opportunity.\u00a0 On the one hand, when companies merge, especially large companies, there are opportunities for other firms, especially smaller ones, to pick up new products that were spun off.\u00a0 On the other hand, there are several news items about new products and technologies that can open up new markets in animal health.\u00a0 Many are developments from companies that you may not have heard of before.\u00a0 All in all, it demonstrates the vibrancy of our industry, an important characteristic at a time when there are major challenges.\u00a0 Be glad that you picked animal health and nutrition for a career instead of, say, hospitality and travel.<\/p>\n<p><em>John Volk<\/em><\/p>\n<p>***********************************<br \/>\n<strong>YOUR VIEW<\/strong><\/p>\n<p>Last week we ask your expectations for 3Q20. 41% think results will be better than expected. 53% said worse.\u00a0 6% hadn\u2019t heard back from their tarot card reader yet.<\/p>\n<p><strong>This week\u2019s poll<\/strong><br \/>\nThis week we want to know about veterinary conferences.\u00a0 As you know, most conferences are being hosted online rather than in person.<\/p>\n<p>If you normally go to conferences in person, are you likely to attend those same conferences virtually this year? [yes or no]<\/p>\n<p>Likewise, if your company typically exhibits at veterinary conferences, will you exhibit at the online versions this year or sit this one out? [Will exhibit.\u00a0 Will not exhibit. Haven\u2019t decided yet.]<\/p>\n<p><a href=\"https:\/\/www.surveymonkey.com\/r\/6MS27HS\"><strong>Click here<\/strong><\/a> to share your thoughts.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>*********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 17 de julho de 2020 Copyright \u00a9 Brakke Editora Consultora: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: Outras Not\u00edcias Antech Diagn\u00f3stico Bayer Biomin Elanco (Bayer) Elanco (Neogen) Dechra Gravity Payments GrowSafe Systems HoverHeat Invetx Kemin Industries LexaGene Neogen (Elanco) Neogen (Soleris) PetIQ Twist Bioscience Vet2Pet VetCell Therapeutics Vytelle Wheatsheaf Group Zoetis *********** ************************* COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA A Elanco Animal Health Incorporated anunciou que a empresa recebeu aprova\u00e7\u00e3o un\u00e2nime da Comiss\u00e3o Federal de Com\u00e9rcio dos EUA (FTC) para sua aquisi\u00e7\u00e3o da Bayer Animal Health. A aprova\u00e7\u00e3o da FTC est\u00e1 condicionada aos seguintes desinvestimentos propostos: Direitos mundiais do Osurnia da Elanco, um tratamento para otite externa em c\u00e3es, sendo vendido \u00e0 Dechra Pharmaceuticals PLC; Direitos nos EUA do Capstar da Elanco, um comprimido oral que mata pulgas em c\u00e3es e gatos, sendo vendido \u00e0 PetIQ, Inc.; Direitos dos EUA para o StandGuard da Elanco, um tratamento para controle de mosca-dos-chifres e piolhos em bovinos de corte, sendo vendido para a Neogen Corporation. A decis\u00e3o da FTC representa a autoriza\u00e7\u00e3o antitruste final necess\u00e1ria para concluir a transa\u00e7\u00e3o, que continua em vias de ser conclu\u00edda no in\u00edcio de agosto. A Elanco tamb\u00e9m recebeu o consentimento do Competition Bureau do Canad\u00e1, enquanto se aguarda a aliena\u00e7\u00e3o da Osurnia e do Profender da Bayer, bem como o compromisso da Elanco de renunciar \u00e0 aquisi\u00e7\u00e3o dos direitos de distribui\u00e7\u00e3o canadenses das aves Tempo, Credo, QuickBayt e Annihilator Polyzone da Bayer.<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-july-17-2020\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-28342","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-july-17-2020\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for July 17, 2020 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Other News Antech Diagnostics Bayer Biomin Elanco (Bayer) Elanco (Neogen) Dechra Gravity Payments GrowSafe Systems HoverHeat Invetx Kemin Industries LexaGene Neogen (Elanco) Neogen (Soleris) PetIQ Twist Bioscience Vet2Pet VetCell Therapeutics Vytelle Wheatsheaf Group Zoetis ************************************ COMPANY NEWS RELEASES Elanco Animal Health Incorporated announced that the company has received unanimous approval from the U.S. Federal Trade Commission (FTC) for its acquisition of Bayer Animal Health. The FTC\u2019s approval is conditional on the following proposed divestitures: Worldwide rights for Elanco\u2019s Osurnia, a treatment for otitis externa in dogs, being sold to Dechra Pharmaceuticals PLC; US rights for Elanco\u2019s Capstar, an oral tablet that kills fleas in dogs and cats, being sold to PetIQ, Inc.; US rights for Elanco\u2019s StandGuard, a pour-on treatment for horn fly and lice control in beef cattle, being sold to Neogen Corporation. The FTC decision represents the final antitrust clearance needed to complete the transaction, which continues on track for closing at the beginning of August. Elanco also received consent from Canada\u2019s Competition Bureau, pending the divestiture of Osurnia and Bayer\u2019s Profender, as well as Elanco&#8217;s commitment to forego acquiring the Canadian distribution rights to Bayer&#8217;s Tempo, Credo, QuickBayt and Annihilator Polyzone poultryView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-july-17-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-17T01:45:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-07-17T01:47:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for July 17, 2020\",\"datePublished\":\"2020-07-17T01:45:50+00:00\",\"dateModified\":\"2020-07-17T01:47:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/\"},\"wordCount\":1248,\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg\",\"datePublished\":\"2020-07-17T01:45:50+00:00\",\"dateModified\":\"2020-07-17T01:47:03+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#primaryimage\",\"url\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg\",\"contentUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/zh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for July 17, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-july-17-2020\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for July 17, 2020 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Other News Antech Diagnostics Bayer Biomin Elanco (Bayer) Elanco (Neogen) Dechra Gravity Payments GrowSafe Systems HoverHeat Invetx Kemin Industries LexaGene Neogen (Elanco) Neogen (Soleris) PetIQ Twist Bioscience Vet2Pet VetCell Therapeutics Vytelle Wheatsheaf Group Zoetis ************************************ COMPANY NEWS RELEASES Elanco Animal Health Incorporated announced that the company has received unanimous approval from the U.S. Federal Trade Commission (FTC) for its acquisition of Bayer Animal Health. The FTC\u2019s approval is conditional on the following proposed divestitures: Worldwide rights for Elanco\u2019s Osurnia, a treatment for otitis externa in dogs, being sold to Dechra Pharmaceuticals PLC; US rights for Elanco\u2019s Capstar, an oral tablet that kills fleas in dogs and cats, being sold to PetIQ, Inc.; US rights for Elanco\u2019s StandGuard, a pour-on treatment for horn fly and lice control in beef cattle, being sold to Neogen Corporation. The FTC decision represents the final antitrust clearance needed to complete the transaction, which continues on track for closing at the beginning of August. Elanco also received consent from Canada\u2019s Competition Bureau, pending the divestiture of Osurnia and Bayer\u2019s Profender, as well as Elanco&#8217;s commitment to forego acquiring the Canadian distribution rights to Bayer&#8217;s Tempo, Credo, QuickBayt and Annihilator Polyzone poultryView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-july-17-2020\/","og_site_name":"Brakke Consulting Website","article_published_time":"2020-07-17T01:45:50+00:00","article_modified_time":"2020-07-17T01:47:03+00:00","og_image":[{"url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg","type":"","width":"","height":""}],"author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for July 17, 2020","datePublished":"2020-07-17T01:45:50+00:00","dateModified":"2020-07-17T01:47:03+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/"},"wordCount":1248,"image":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg","articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/","url":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#primaryimage"},"image":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg","datePublished":"2020-07-17T01:45:50+00:00","dateModified":"2020-07-17T01:47:03+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#primaryimage","url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg","contentUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/07\/Stock-Table-7.17.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-july-17-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for July 17, 2020"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/28342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=28342"}],"version-history":[{"count":3,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/28342\/revisions"}],"predecessor-version":[{"id":28346,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/28342\/revisions\/28346"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=28342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=28342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=28342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}